Literature DB >> 17298770

Diagnosis and treatment of the neuromuscular manifestations of lyme disease.

John J Halperin1.   

Abstract

Although estimates vary, the nervous system appears to be involved in 10% to 15% of patients infected with Borrelia burgdorferi. The resulting disorders, known collectively as neuroborreliosis or nervous system Lyme disease, generally respond well to antimicrobial therapy. Definitive treatment of nervous system infection typically consists of 2 to 4 weeks of parenteral ceftriaxone, cefotaxime, or high-dose penicillin (Class III). However, numerous European studies have shown that oral doxycycline is equally effective in patients with Lyme meningitis and cranial neuritis (Class II and III). This may be equally valid in patients infected with the strains prevalent in the United States, but this remains to be established.

Entities:  

Year:  2007        PMID: 17298770     DOI: 10.1007/s11940-007-0035-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  39 in total

1.  Neuroborreliosis (Nervous System Lyme Disease).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

4.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

5.  Lyme neuroborreliosis. Peripheral nervous system manifestations.

Authors:  J Halperin; B J Luft; D J Volkman; R J Dattwyler
Journal:  Brain       Date:  1990-08       Impact factor: 13.501

6.  Acute peripheral facial palsy in Lyme disease -- a distal neuritis at the infection site.

Authors:  H Eiffert; A Karsten; T Schlott; A Ohlenbusch; R Laskawi; M Hoppert; H-J Christen
Journal:  Neuropediatrics       Date:  2004-10       Impact factor: 1.947

7.  Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.

Authors:  M Karlsson; S Hammers-Berggren; L Lindquist; G Stiernstedt; B Svenungsson
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

8.  The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.

Authors:  Miikka Peltomaa; Gail McHugh; Allen C Steere
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

9.  Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

Authors:  R F Kaplan; R P Trevino; G M Johnson; L Levy; R Dornbush; L T Hu; J Evans; A Weinstein; C H Schmid; M S Klempner
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

Review 10.  Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E L Logigian; M F Finkel; R A Pearl
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  1 in total

Review 1.  Treatment of Lyme borreliosis.

Authors:  Hermann J Girschick; Henner Morbach; Dennis Tappe
Journal:  Arthritis Res Ther       Date:  2009-12-17       Impact factor: 5.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.